Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Biochemical and Biophysical Research Communications|April 9, 2009
Crystal structure of a catalytically active, non-toxic endopeptidase derivative of Clostridium botulinum toxin AGeoffrey Masuyer, Nethaji Thiyagarajan, Peter L James, et al.
The Journal of Biological Chemistry|December 4, 2013
Molecular and thermodynamic mechanisms of the chloride-dependent human angiotensin-I-converting enzyme (ACE)Christopher J Yates, Geoffrey Masuyer, Sylva L U Schwager, et al.
The FEBS Journal|January 11, 2016
Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzymeKate M Larmuth, Geoffrey Masuyer, Ross G Douglas, et al.
Journal of the American Chemical Society|December 14, 2016
Glycans Confer Specificity to the Recognition of Ganglioside Receptors by Botulinum Neurotoxin AChristoffer Hamark, Ronnie P-A Berntsson, Geoffrey Masuyer, et al.
The Journal of Biological Chemistry|September 21, 2019
Structural basis for the interaction of the chaperone Cbp3 with newly synthesized cytochrome b during mitochondrial respiratory chain assemblyMama Ndi, Geoffrey Masuyer, Hannah Dawitz, et al.
Human Molecular Genetics|October 29, 2013
Absence of cell surface expression of human ACE leads to perinatal deathAnnie Michaud, K Ravi Acharya, Geoffrey Masuyer, et al.
Communications Biology|March 12, 2025
Discovery of mono-ADP ribosylating toxins with high structural homology to Pseudomonas exotoxin AGeoffrey Masuyer, Alistair Taverner, Julia MacKay, et al.
The FEBS Journal|December 7, 2011
Engineering botulinum neurotoxin domains for activation by toxin light chainPatrick R Stancombe, Geoffrey Masuyer, Ian Birch-Machin, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Interkingdom pharmacology of Angiotensin-I converting enzyme inhibitor phosphonates produced by actinomycetesGlenna J Kramer, Akif Mohd, Sylva L U Schwager, et al.
Clinical Science (London, England : 1979)|September 11, 2013
Fragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitorsRoss G Douglas, Rajni K Sharma, Geoffrey Masuyer, et al.
Pageof 5